반려동물 웰니스 분석 시장 예측(-2034년) : 솔루션 유형, 동물 종류, 용도, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Companion Animal Wellness Analytics Market is accounted for $1.6 billion in 2026 and is expected to reach $3.4 billion by 2034 growing at a CAGR of 9.9% during the forecast period. Companion Animal Wellness Analytics refers to the collection, integration, and analysis of health, behavioral, physiological, and lifestyle data from companion animals to assess overall well-being and identify potential health risks. It utilizes advanced technologies such as wearable devices, sensors, digital health platforms, and data analytics tools to generate actionable insights regarding an animal's physical condition, activity levels, nutrition, and wellness trends. The primary objective of companion animal wellness analytics is to support preventive care, enable personalized health management, improve early intervention strategies, and enhance the long-term quality of life of pets.

Market Dynamics:

Driver:

Preventive care adoption growth

A fundamental shift in companion animal healthcare philosophy from reactive treatment to proactive wellness management is creating sustained demand for data-driven analytics platforms. Veterinary professional associations are increasingly advocating annual wellness screening protocols supported by longitudinal health data tracking. Pet owners who have experienced the financial and emotional costs of advanced-stage disease treatment demonstrate strong receptiveness to preventive analytics tools. Pet insurance carriers are incentivizing preventive care adoption through premium reduction programs linked to verified wellness protocol compliance. The convergence of consumer health quantification trends with pet humanization behaviors creates natural demand transfer from personal health analytics to companion animal equivalents.

Restraint:

Data integration complexity barriers

The fragmented ecosystem of companion animal health data sources, including wearable device streams, veterinary practice management systems, laboratory records, and dietary logs, creates significant technical integration barriers for comprehensive wellness analytics platform development. Proprietary data formats used by major veterinary practice management software vendors limit interoperability with third-party analytics tools. The absence of universal companion animal health data exchange standards comparable to human healthcare HL7 FHIR protocols prevents seamless longitudinal record consolidation. Small and independent veterinary practices lack an IT infrastructure to support data-intensive platform integrations, restricting market access in a large segment of the practitioner base.

Opportunity:

Pet insurance risk analytics

The expanding pet insurance industry presents a high-value data partnership opportunity for companion animal wellness analytics platform providers. Insurers require predictive risk models that accurately price chronic disease probability, breed-specific health trajectories, and lifestyle factor influences on claim frequency. Longitudinal wellness data collected through analytics platforms provides the actuarial foundation for usage-based insurance products that reward preventive care behaviors. Partnerships between wellness platform operators and insurance carriers create bundled subscription offerings that improve customer retention and reduce policy lapse rates. The mutual commercial interest in disease prevention creates aligned incentive structures that accelerate co-development of integrated wellness-insurance products.

Threat:

Veterinary adoption resistance

Resistance to workflow change and technology adoption among established veterinary practitioners represents a significant deployment barrier for companion animal wellness analytics platforms. Many veterinarians trained in conventional clinical examination and diagnostic methodologies express skepticism regarding algorithm-generated wellness scores and predictive health recommendations that lack direct practitioner clinical judgment input. Data entry burden associated with populating analytics platforms alongside existing practice management systems creates workflow friction that reduces sustained engagement. The perceived risk of algorithm-generated recommendations conflicting with practitioner clinical assessment creates liability concerns that suppresses institutional adoption. Continuing education investment requirements for effective platform utilization constrain adoption velocity.

Covid-19 Impact:

The COVID-19 pandemic accelerated digital health platform adoption across both human and companion animal healthcare sectors as clinics sought remote patient monitoring solutions during restricted in-person visit periods. Pet adoption surges permanently expanded the longitudinal health data generation potential of the companion animal population. Pandemic-era pet owners demonstrated heightened engagement with digital health tracking applications, creating habitual usage patterns that persist post-crisis. Venture capital investment in digital pet health platforms accelerated significantly during and after the pandemic, enabling the development of more sophisticated analytics capabilities that are reaching commercial maturity.

The software platforms segment is expected to be the largest during the forecast period

The software platforms segment is expected to account for the largest market share during the forecast period, due to its central role as the data aggregation, processing, and insight delivery layer that defines user value in companion animal wellness analytics ecosystems. Cloud-based software platforms that unify data streams from multiple devices and veterinary record sources enable the longitudinal health trend analyses that constitute the core product value proposition. Subscription-based software revenue models generate recurring income that supports continuous feature development and customer retention. Major market participants, including IDEXX Laboratories Inc. and Mars Petcare, are building proprietary analytics software platforms that integrate with their broader veterinary service and product ecosystems.

The dogs segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the dogs segment is predicted to witness the highest growth rate, driven by the dominant global companion animal population of dogs and the most extensive behavioral science and health monitoring research base that enables more accurate and actionable analytics outputs. Dog health analytics platforms benefit from large training datasets that improve machine learning model accuracy for activity pattern classification, disease risk prediction, and behavioral anomaly detection. The strong owner emotional investment in canine health outcomes and established willingness to pay for premium preventive care services directly support platform adoption and subscription retention. Breed-specific analytics capabilities addressing genetically elevated disease risks create differentiated clinical utility.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the most advanced pet health data infrastructure, the highest concentration of wellness analytics platform developers, and the most mature pet insurance market that creates institutional demand for data-driven risk analytics. The United States hosts leading companies including Whistle Labs Inc., PetPace, FitBark, and Anivive Lifesciences. Strong veterinary technology investment in the region funds continuous platform capability development. Consumer health quantification behaviors that are most advanced in North America transfer naturally to companion animal wellness monitoring adoption patterns.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly expanding pet ownership in China, Japan, South Korea, and Australia and increasing owner investment in preventive companion animal healthcare. Growing pet insurance penetration in Japan and South Korea is creating institutional demand for wellness data analytics that support actuarial modeling. Domestic technology companies are developing AI-driven pet wellness platforms adapted to regional veterinary care standards and species preferences. Rising health awareness among millennial and Generation Z pet owners translates directly into demand for data-driven wellness management tools.

Key players in the market

Some of the key players in Companion Animal Wellness Analytics Market include IDEXX Laboratories Inc., Zoetis Inc., Mars Petcare, Nestle Purina Petcare, Whistle Labs Inc., PetPace, FitBark, Garmin Ltd., PetSafe Brands, Sure Petcare Limited, Anivive Lifesciences, Medtronic Plc, Virbac SA, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., and Heska Corporation.

Key Developments:

In May 2026, Mars Petcare launched Wisdom Health Analytics 2.0, an AI-powered companion animal wellness platform integrating genetic health risk data, wearable activity monitoring, and veterinary diagnostic records to generate personalized preventive care timelines for dogs and cats.

In April 2026, Whistle Labs Inc. introduced a Veterinary Decision Support module within its wellness analytics platform, providing participating veterinary clinics with longitudinal activity, sleep, and nutritional data summaries to inform annual wellness examination clinical assessments.

In March 2026, Zoetis Inc. expanded its Vetscan VUE wellness analytics service with an AI-based chronic disease progression scoring tool for dogs with diabetes and renal disease, enabling early intervention alerts based on longitudinal analysis of biomarkers and activity trends.

Solution Types Covered:

• Software Platforms
• Hardware Devices
• Services
• Integrated Platforms

Animal Types Covered:

• Dogs
• Cats
• Horses
• Small Mammals
• Birds
• Exotic Pets

Applications Covered:

• Preventive Care
• Chronic Disease Management
• Nutrition and Diet Planning
• Behavioral Analytics
• Fitness and Activity Tracking
• Veterinary Decision Support
• Insurance Risk Assessment

End Users Covered:

• Veterinary Hospitals and Clinics
• Pet Owners
• Pet Insurance Companies
• Research Organizations
• Animal Welfare Organizations
• Pet Food Companies

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Companion Animal Wellness Analytics Market, By Solution Type

• 5.1 Software Platforms
• 5.2 Hardware Devices
• 5.3 Services
• 5.4 Integrated Platforms

6 Global Companion Animal Wellness Analytics Market, By Animal Type

• 6.1 Dogs
• 6.2 Cats
• 6.3 Horses
• 6.4 Small Mammals
• 6.5 Birds
• 6.6 Exotic Pets

7 Global Companion Animal Wellness Analytics Market, By Application

• 7.1 Preventive Care
• 7.2 Chronic Disease Management
• 7.3 Nutrition and Diet Planning
• 7.4 Behavioral Analytics
• 7.5 Fitness and Activity Tracking
• 7.6 Veterinary Decision Support
• 7.7 Insurance Risk Assessment

8 Global Companion Animal Wellness Analytics Market, By End User

• 8.1 Veterinary Hospitals and Clinics
• 8.2 Pet Owners
• 8.3 Pet Insurance Companies
• 8.4 Research Organizations
• 8.5 Animal Welfare Organizations
• 8.6 Pet Food Companies

9 Global Companion Animal Wellness Analytics Market, By Geography

• 9.1 North America
  • 9.1.1 United States
  • 9.1.2 Canada
  • 9.1.3 Mexico
• 9.2 Europe
  • 9.2.1 United Kingdom
  • 9.2.2 Germany
  • 9.2.3 France
  • 9.2.4 Italy
  • 9.2.5 Spain
  • 9.2.6 Netherlands
  • 9.2.7 Belgium
  • 9.2.8 Sweden
  • 9.2.9 Switzerland
  • 9.2.10 Poland
  • 9.2.11 Rest of Europe
• 9.3 Asia Pacific
  • 9.3.1 China
  • 9.3.2 Japan
  • 9.3.3 India
  • 9.3.4 South Korea
  • 9.3.5 Australia
  • 9.3.6 Indonesia
  • 9.3.7 Thailand
  • 9.3.8 Malaysia
  • 9.3.9 Singapore
  • 9.3.10 Vietnam
  • 9.3.11 Rest of Asia Pacific
• 9.4 South America
  • 9.4.1 Brazil
  • 9.4.2 Argentina
  • 9.4.3 Colombia
  • 9.4.4 Chile
  • 9.4.5 Peru
  • 9.4.6 Rest of South America
• 9.5 Rest of the World (RoW)
  • 9.5.1 Middle East
    • 9.5.1.1 Saudi Arabia
    • 9.5.1.2 United Arab Emirates
    • 9.5.1.3 Qatar
    • 9.5.1.4 Israel
    • 9.5.1.5 Rest of Middle East
  • 9.5.2 Africa
    • 9.5.2.1 South Africa
    • 9.5.2.2 Egypt
    • 9.5.2.3 Morocco
    • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

• 10.1 Industry Value Network and Supply Chain Assessment
• 10.2 White-Space and Opportunity Mapping
• 10.3 Product Evolution and Market Life Cycle Analysis
• 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

• 11.1 Mergers and Acquisitions
• 11.2 Partnerships, Alliances, and Joint Ventures
• 11.3 New Product Launches and Certifications
• 11.4 Capacity Expansion and Investments
• 11.5 Other Strategic Initiatives

12 Company Profiles

• 12.1 IDEXX Laboratories Inc.
• 12.2 Zoetis Inc.
• 12.3 Mars Petcare
• 12.4 Nestle Purina Petcare
• 12.5 Whistle Labs Inc.
• 12.6 PetPace
• 12.7 FitBark
• 12.8 Garmin Ltd.
• 12.9 PetSafe Brands
• 12.10 Sure Petcare Limited
• 12.11 Anivive Lifesciences
• 12.12 Medtronic Plc
• 12.13 Virbac SA
• 12.14 Boehringer Ingelheim International GmbH
• 12.15 Elanco Animal Health Inc.
• 12.16 Heska Corporation